Felty's syndrome, multiple sites
ICD-10 M05.09 is a billable code used to indicate a diagnosis of felty's syndrome, multiple sites.
Felty's syndrome is a rare autoimmune disorder characterized by the triad of rheumatoid arthritis (RA), splenomegaly, and neutropenia. It primarily affects the musculoskeletal system, leading to joint inflammation and damage. Anatomically, the condition involves multiple joints, particularly the hands, wrists, and knees, where synovial inflammation occurs, resulting in pain, swelling, and reduced mobility. The pathophysiology involves an autoimmune response where the body’s immune system mistakenly attacks its own tissues, particularly affecting the synovial membranes of joints. Clinically, patients present with symptoms of RA, including morning stiffness, joint deformities, and systemic symptoms such as fatigue and weight loss. The presence of splenomegaly can lead to increased risk of infections due to neutropenia, complicating the management of joint symptoms. Overall, Felty's syndrome requires a multidisciplinary approach for effective management, including rheumatologic and orthopedic interventions.
Orthopedic documentation should include imaging studies (X-rays, MRIs) to assess joint damage, functional assessments to evaluate mobility, and detailed descriptions of any surgical interventions.
Common scenarios include surgical interventions for joint deformities or severe arthritis, such as arthroplasty or synovectomy.
Joint-specific considerations include documenting the severity of joint involvement, range of motion limitations, and any surgical history.
Rheumatologic documentation must include laboratory tests for rheumatoid factor, anti-CCP antibodies, and complete blood counts to monitor neutrophil levels and disease activity.
Clinical scenarios often involve managing flare-ups of RA symptoms, adjusting DMARD therapy, and monitoring for complications related to neutropenia.
Systemic involvement must be documented, including any signs of splenomegaly and infections, as well as the impact on overall health.
Functional assessments should evaluate the patient's ability to perform daily activities, mobility assessments, and any need for assistive devices.
Rehabilitation scenarios may include physical therapy for joint mobility and strength training to improve function.
Mobility limitations should be documented, including the need for assistive devices like walkers or braces.
Used for joint swelling management in Felty's syndrome patients.
Document the joint involved, amount of fluid removed, and any therapeutic agents injected.
Orthopedic considerations include assessing joint stability and potential for further intervention.
Key symptoms include joint pain and swelling due to rheumatoid arthritis, splenomegaly, and recurrent infections due to neutropenia. Patients may also experience fatigue and weight loss.
